PIP Framework Advisory Group Consultations,
21 March 2013
The PIP Framework Advisory Group Chair and Vice Chair, Professor Didier Houssin and Professor Tjandra Aditama, cordially invite influenza vaccine, diagnostic and pharmaceutical manufacturers, associations, civil society organizations and other stakeholders (including academia and research institutions) to consultations on 21 March 2013 to discuss “Use of the Partnership Contribution” (see Pandemic influenza preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits, Section 6.14.6).
All meetings will be held in WHO Headquarters, Main Building, Salle B.
Audio streaming available.
Meeting times are as follows:
09.45 – 10.45 Advisory Group consultation with influenza vaccine, diagnostic and pharmaceutical manufacturers.
11.15 – 12.15 Advisory Group consultation with civil society organizations and other stakeholders.
13.30 – 15.00 Advisory Group joint discussion with industry, civil society and other stakeholders.
Please confirm your intent to participate no later than Wednesday, 13 March 2013 by sending your email response to email@example.com with your name, title, affiliation and contact details so a badge to enter WHO can be issued.
If you are interested in listening to a session via a live audio link over the internet, please send your name, title and affiliation to firstname.lastname@example.org and include "Audio registration" (please specify "stakeholder" or "manufacturer") in your subject line by Wednesday, 13 March 2013. We will send you a link to the relevant session.
If you have specific questions for the Advisory Group on the topic of use of the Partnership Contribution, we would be grateful to receive them in advance so that the Advisory Group may be prepared to answer them. Questions should be sent by email to email@example.com.